Author

Dietmar Falke

Institution: Grünenthal Group (Germany)

Observed institutions: University of North Carolina at Chapel Hill, Grünenthal Group (Germany)

OpenAlex ID: A5113672553

Effectiveness of Tapentadol Prolonged Release ( PR ) Compared with Oxycodone/Naloxone PR for the Management of Severe Chronic Low Back Pain with a Neuropathic Component: A Randomized, Controlled, Open‐Label, Phase 3b/4 Study

2015 · Ralf Baron, Rudolf Likar, et al. · Pain Practice · 73

Effectiveness and Safety of Tapentadol Prolonged Release ( PR ) Versus a Combination of Tapentadol PR and Pregabalin for the Management of Severe, Chronic Low Back Pain With a Neuropathic Component: A Randomized, Double‐blind, Phase 3b Study

2014 · Ralf Baron, Emilio Martin‐Mola, et al. · Pain Practice · 71

Tolerability, Safety, and Quality of Life with Tapentadol Prolonged Release ( PR ) Compared with Oxycodone/Naloxone PR in Patients with Severe Chronic Low Back Pain with a Neuropathic Component: A Randomized, Controlled, Open‐label, Phase 3b/4 Trial

2015 · Ralf Baron, Jan‐Peter Jansen, et al. · Pain Practice · 68

Effectiveness and Tolerability of Tapentadol Prolonged Release Compared With Prior Opioid Therapy for the Management of Severe, Chronic Osteoarthritis Pain

2013 · Ilona Steigerwald, Michael Schenk, et al. · Clinical Drug Investigation · 48

Tapentadol Prolonged Release Versus Strong Opioids for Severe, Chronic Low Back Pain: Results of an Open-Label, Phase 3b Study

2013 · Rafael Gálvez, Michael Schäfer, et al. · Advances in Therapy · 46

Effectiveness and Tolerability of a Moderate Dose of Tapentadol Prolonged Release for Managing Severe, Chronic Low Back Pain with a Neuropathic Component: An Open‐label Continuation Arm of a Randomized Phase 3b Study

2014 · Ralf Baron, Uwe Kern, et al. · Pain Practice · 36

Selective gene regulation with designed transcription factors: implications for therapy.

2003 · Dietmar Falke, Rudy L Juliano · PubMed · 21

Effects of tapentadol prolonged release treatment on neuropathic pain symptoms in patients with chronic low back pain: results from an open-label, Phase 3b study

2012 · Dietmar Falke, S. Groblschegg, et al. · F1000Research

Works count: 8

Citation count: 363

H-index: 7

I10-index: 7